About Bicycle Health
Bicycle Health provides online treatment for opioid use disorder (OUD) through a secure app, allowing patients to receive care without visiting a physical clinic. Their main service is Medication for Addiction Treatment (MAT), which helps patients stop using opioids with minimal discomfort, leading to better recovery outcomes. The company accepts most major insurance plans, generating revenue through reimbursements for clinical care, therapy, and support. Bicycle Health distinguishes itself with a full-time care team that offers personalized support and quick access to Suboxone prescriptions. The goal of Bicycle Health is to deliver effective, patient-centered care that helps individuals rebuild their lives.
Boston, MassachusettsHeadquarters
2017Year Founded
$84.9MTotal Funding
SERIES_BCompany Stage
Consumer Software, HealthcareIndustries
51-200Employees
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Disability Insurance
Paid Vacation
Paid Sick Leave
401(k) Retirement Plan
Home Office Stipend
Remote Work Options
Risks
Talkspace's Behavioral Health Consortium may divert potential patients from Bicycle Health.
Bicycle Health's expansion to adolescents in Maine may face regulatory challenges.
Partnership with Wellpath exposes Bicycle Health to correctional healthcare compliance risks.
Differentiation
Bicycle Health offers same-day Suboxone prescriptions, enhancing its value proposition.
The company provides a secure app for convenient, remote opioid use disorder treatment.
Bicycle Health's patient-centric approach is highlighted by positive testimonials from over 20,000 patients.
Upsides
Increased telehealth demand post-COVID-19 boosts Bicycle Health's reach and patient base.
Growing insurance acceptance of digital health eases reimbursement for Bicycle Health's services.
Public health focus on substance use disorder may drive funding for Bicycle Health.
Funding
Total raised$84.92 M
Latest valuation$250.00 M
StageSERIES_B
SERIES B
8/31/2022$5
$250.00 MSERIES A
5/31/2021$27
$135.00 MEARLY VC
4/30/2020$5
$26.50 M